ANGO vs MTD · rev $292.5M vs P/E 27, rev $3.87B
AngioDynamics Inc (ANGO) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
ANGO currently screens at market cap $378.5M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the ANGO and MTD stock pages for the full models.
Not investment advice.